Literature DB >> 22874478

Viral load monitoring in resource-limited settings: a medical and public health priority.

Nathan Ford, Teri Roberts, Alexandra Calmy.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22874478     DOI： 10.1097/QAD.0b013e3283543e2c

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Authors:  Cynthia Riviere; Elizabeth Faust; Thane Miller; Eduard J Beck; Elaine Baruwa; Patrice Severe; Karine Severe; Claudia Thomas Riché; Rachelle Cassagnol; Sidney Atwood; Morgan Esperance; Lauren Webster; Pierre Cremieux; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

2.  Association Between Self-Reported Adherence and HIV Viral Load Suppression Among Older Children and Adolescents.

Authors:  Chido Dziva Chikwari; Rashida A Ferrand; Victoria Simms
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

Review 3.  Developments in CD4 and viral load monitoring in resource-limited settings.

Authors:  Christopher F Rowley
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

4.  Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting.

Authors:  Samantha Stonbraker; Montina Befus; Leonel Lerebours Nadal; Mina Halpern; Elaine Larson
Journal:  Int J STD AIDS       Date:  2016-08-05       Impact factor: 1.359

Review 5.  Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring.

Authors:  Trevor Peter; Dennis Ellenberger; Andrea A Kim; Debrah Boeras; Tsehaynesh Messele; Teri Roberts; Wendy Stevens; Ilesh Jani; Alash'le Abimiku; Nathan Ford; Zachary Katz; John N Nkengasong
Journal:  Lancet Infect Dis       Date:  2016-10-20       Impact factor: 25.071

6.  Priorities for developing countries in the global response to non-communicable diseases.

Authors:  Dermot Maher; Nathan Ford; Nigel Unwin
Journal:  Global Health       Date:  2012-06-11       Impact factor: 4.185

7.  Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.

Authors:  Palvinder Kaur; Wei Xin Khong; Sue Yuen Wee; Eng Lee Tan; Juergen Pipper; Evelyn Koay; Kah Ying Ng; Joe Kwan Yap; Kuan Kiat Chew; Mei Ting Tan; Yee Sin Leo; Masafumi Inoue; Oon Tek Ng
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 8.  Getting to zero HIV deaths: progress, challenges and ways forward.

Authors:  Nathan Ford; Marco Vitoria; Gottfried Hirnschall; Meg Doherty
Journal:  J Int AIDS Soc       Date:  2013-12-01       Impact factor: 5.396

9.  First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.

Authors:  Nathan Clumeck; Claude Mwamba; Kabamba Kabeya; Serge Matanda; Dolorès Vaira; Coca Necsoi; David Kadiebwe; Marc Delforge; Eric Kasamba; Chantal Milolo; Joe Ilunga; Liévin Kapend
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

Review 10.  Can we stop AIDS with antiretroviral-based treatment as prevention?

Authors:  Edward J Mills; Jean B Nachega; Nathan Ford
Journal:  Glob Health Sci Pract       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.